Virus-like Particles in Plants for Vaccine Development
Author Information
Author(s): Mardanova Eugenia S., Vasyagin Egor A., Ravin Nikolai V.
Primary Institution: Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow, Russia
Hypothesis
Virus-like particles (VLPs) produced in plants can serve as an effective platform for recombinant vaccine development.
Conclusion
The study highlights the potential of using plant-derived virus-like particles as a safe and cost-effective method for producing vaccines.
Supporting Evidence
- Virus-like particles can induce strong immune responses without containing viral genomes.
- Plants can produce recombinant proteins at lower costs and with higher safety compared to traditional methods.
- Transient expression systems allow for rapid production of vaccine candidates during epidemics.
Takeaway
Scientists are using plants to make tiny particles that look like viruses to help create vaccines. This method is safe and can be done quickly.
Methodology
The review discusses various methods for producing virus-like particles in plants, including transient expression systems and the use of Agrobacterium for gene transfer.
Limitations
The variability in protein expression levels and challenges in protein purification from plants are noted as significant limitations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website